Fig. 6

The putative B-cell epitopes present in the constructed vaccine. The violet spheres displayed epitopes containing (a) 70 residues (AA 335–396, AA 401–408) with a residue score of 0.802 (b) 36 residues (AA 133–154, AA 156–163, AA 177–182) with residue score of 0.69 (c) 97 residues (AA 1–5, AA 7–8, AA 11–12, AA 15–16, AA 19–20, AA 23, AA 27–28, AA 227–261, AA 270–272, AA 275–276, AA 278–296, AA 298–314, AA 316–320) with residue score of 0.683 (d) 14 residues (AA 52, AA 55–57, AA 59–63, AA 84–88) with residue score of 0.613 (e) 4 residues (AA 108–111) with residue score of 0.553 (f) 10 residues (AA 416–425) with residue score of 0.503.